Free. Unsubscribe any time.
ACADIA PHARMACEUTICALS INC (ACAD)
ACADIA PHARMACEUTICALS INC filed 27 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 35 transactions and 151,813 shares. None carries the SEC's AFF10B5ONE flag; all 27 name a plan in a footnote. 8 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-08-07, came 7 days after the one before it (2026-07-31) and reports 7 transactions against 4 in the filing before it.
- The sales it reports total 20,141 shares, 3,583 more than the 16,558 in the filing before it.
- Its 27 plan statements rank 224th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 3 have more plan statements on file than it and 7 have fewer.
- Its 27 filings on file run from 2025-02-25 to 2026-08-07, and state 4 plan adoption dates, from 2024-05-30 to 2025-12-09.
Trades in ACADIA PHARMACEUTICALS INC 35
- Kihara James — 2025-02-24 · S · 475 shares
- Schneyer Mark C. — 2025-02-24 · S · 773 shares
- Kihara James — 2025-03-26 · S · 1,095 shares
- Schneyer Mark C. — 2025-03-26 · S · 3,171 shares
- Kihara James — 2025-04-08 · S · 1,028 shares
- Schneyer Mark C. — 2025-04-08 · S · 2,708 shares
- Kihara James — 2025-05-02 · S · 1,327 shares
- Schneyer Mark C. — 2025-05-02 · S · 3,498 shares
- Kihara James — 2025-05-16 · S · 2,000 shares
- Kihara James — 2025-05-16 · S · 2,000 shares
- Schneyer Mark C. — 2025-05-16 · S · 2,000 shares
- Schneyer Mark C. — 2025-08-18 · S · 22,000 shares
Adoption dates in ACADIA PHARMACEUTICALS INC 4
- 2024-05-30 — stated in 1 filing
- 2024-11-18 — stated in 1 filing
- 2025-05-19 — stated in 2 filings
- 2025-12-09 — stated in 1 filing
Results prints in ACADIA PHARMACEUTICALS INC 8
- 2025-02-26
- 2025-05-07
- 2025-08-06
- 2025-11-05
- 2026-01-13
- 2026-02-25
- 2026-05-06
- 2026-08-04
Trades before a print in ACADIA PHARMACEUTICALS INC 8
- 2 days before the 2025-02-26 print — 2025-02-24 · S · Kihara James · 475 shares
- 2 days before the 2025-02-26 print — 2025-02-24 · S · Schneyer Mark C. · 773 shares
- 2 days before the 2026-05-06 print — 2026-05-04 · S · Kihara James · 1,332 shares
- 2 days before the 2026-05-06 print — 2026-05-04 · S · Schneyer Mark C. · 3,506 shares
- 5 days before the 2025-05-07 print — 2025-05-02 · S · Kihara James · 1,327 shares
- 5 days before the 2025-05-07 print — 2025-05-02 · S · Schneyer Mark C. · 3,498 shares
- 5 days before the 2026-08-04 print — 2026-07-30 · S · Thompson Elizabeth H.Z. · 16,508 shares
- 5 days before the 2026-08-04 print — 2026-07-30 · S · Thompson Elizabeth H.Z. · 50 shares
- 16 days before the 2026-02-25 print — 2026-02-09 · S · Rhodes Jennifer J · 6,950 shares
- 29 days before the 2025-05-07 print — 2025-04-08 · S · Kihara James · 1,028 shares
- 29 days before the 2025-05-07 print — 2025-04-08 · S · Schneyer Mark C. · 2,708 shares
- 29 days before the 2026-05-06 print — 2026-04-07 · S · Kihara James · 1,030 shares
Interval to ACADIA PHARMACEUTICALS INC’s next reported results date
How the interval and sources are counted →
- 8within 5 days
- 8within 10 days
- 2shortest, days
- 3no later print
- Kihara James 2025-02-24 · S · 2 days before the 2025-02-26 print · PRINCIPAL ACCOUNTING OFFICER
- Schneyer Mark C. 2025-02-24 · S · 2 days before the 2025-02-26 print · EVP, CHIEF FINANCIAL OFFICER
- Kihara James 2025-05-02 · S · 5 days before the 2025-05-07 print · PRINCIPAL ACCOUNTING OFFICER
- Schneyer Mark C. 2025-05-02 · S · 5 days before the 2025-05-07 print · EVP, CHIEF FINANCIAL OFFICER
- Kihara James 2026-05-04 · S · 2 days before the 2026-05-06 print · PRINCIPAL ACCOUNTING OFFICER
- Schneyer Mark C. 2026-05-04 · S · 2 days before the 2026-05-06 print · EVP, CHIEF FINANCIAL OFFICER
- Thompson Elizabeth H.Z. 2026-07-30 · S · 5 days before the 2026-08-04 print · EVP, Head of Research & Dev
- Thompson Elizabeth H.Z. 2026-07-30 · S · 5 days before the 2026-08-04 print · EVP, Head of Research & Dev
Adoption dates ACADIA PHARMACEUTICALS INC states
- 2024-05-30 in 1 filing
- 2024-11-18 in 1 filing
- 2025-05-19 in 2 filings
- 2025-12-09 in 1 filing
Filing text: “10b5-1 trading plan adopted by the Reporting Person on May 30, 2024”
Reported results dates on file
- 2025-02-26
- 2025-05-07
- 2025-08-06
- 2025-11-05
- 2026-01-13
- 2026-02-25
- 2026-05-06
- 2026-08-04
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.